Innoviva, Inc. (INVA) vs Omnicell, Inc. (OMCL)
A side-by-side comparison of Innoviva, Inc. and Omnicell, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INVA
Innoviva, Inc.
$20.92HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
OMCL
Omnicell, Inc.
$35.48HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
Total return — INVA vs OMCL
growth of $100 · dividends reinvested · last 10yINVA +94.5% (+6.9%/yr)OMCL -7.5% (-0.8%/yr)INVA compounded faster over this window
INVA OMCL
INVA vs OMCL: by the numbers
- •OMCL is the larger company ($1.61B vs $1.54B market cap).
- •INVA trades at the lower trailing earnings multiple (5.10 vs 41.99 P/E), one valuation lens rather than an overall verdict.
- •INVA converts more revenue to profit (80.56% vs 3.13% net margin).
- •OMCL grew revenue faster over the past five years (4.77% vs 3.94% CAGR).
Metrics side by side
Valuation
| Metric | INVA | OMCL |
|---|---|---|
| P/E ratio | 5.10 | 41.99 |
| Forward P/E | 8.65 | 15.64 |
| PEG ratio | 0.49 | N/A |
| P/S ratio | 3.48 | 1.29 |
| P/B ratio | 1.25 | 1.25 |
| EV / EBITDA | 4.93 | 10.76 |
| FCF yield | 12.20% | 8.76% |
Profitability
| Metric | INVA | OMCL |
|---|---|---|
| Gross margin | 73.09% | 44.77% |
| Operating margin | 36.66% | 4.73% |
| Net margin | 80.56% | 3.13% |
| ROE | 28.97% | 3.03% |
| ROIC | 8.36% | 2.43% |
Growth (annualized)
| Metric | INVA | OMCL |
|---|---|---|
| Revenue CAGR (5Y) | 3.94% | 4.77% |
| EPS CAGR (5Y) | 12.71% | -43.29% |
| FCF CAGR (5Y) | -10.54% | -8.10% |
| Total return CAGR (5Y) | 4.52% | -26.44% |
Frequently asked
- Which has the lower trailing P/E, INVA or OMCL?
- INVA has the lower trailing P/E: INVA trades at 5.10 and OMCL at 41.99. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, INVA or OMCL?
- Over the past five years, OMCL grew revenue faster — INVA at a 3.94% CAGR versus OMCL at 4.77%.
- Is INVA or OMCL more profitable?
- INVA runs the higher net margin — INVA at 80.56% versus OMCL at 3.13%.
- How have INVA and OMCL total returns compared?
- Over the past 10 years, INVA delivered 6.43% and OMCL delivered -0.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Innoviva P/E ratioOmnicell P/E ratioInnoviva ROEOmnicell ROEInnoviva operating marginOmnicell operating marginInnoviva revenue growthOmnicell revenue growthInnoviva free cash flowOmnicell free cash flow
Innoviva & Omnicell appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.